THE National Pharmaceutical Company of Zimbabwe (NTAPHARM) says it has secured funding to procure uninterrupted six months supply of cotrimoxazole an antibiotic used for various bacterial infection and is used by people living with HIV who have a CD4 count of less than 250. By Catherine Murombedzi Speaking at a sensitization meeting for the Northern Region People Living with HIV, Meaningful Involvement People Living with HIV (MIPA) in Kadoma, Natpharm Acting Director, Mr Davison Vuragu said, “The Global Fund, (GF) has funded the six months purchase of cotrimoxazole. With funding…
Read MoreNatpharm Gets 6 Months Cotrimoxazole Funding
